Liabilities / Assets
7th percentile
Higher debt load relative to assets than 7% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
7th percentile
Higher debt load relative to assets than 7% of similar nonprofits.
Liabilities / Revenue
21st percentile
Higher debt load relative to revenue than 21% of similar nonprofits.
Net Margin
5th percentile
Higher net margin than 5% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
5th percentile
Faster asset growth than 5% of similar nonprofits.
Revenue Growth
14th percentile
Faster revenue growth than 14% of similar nonprofits.
Assets
Down$103,602,329
Down $14,067,253 (-12%) from 2015
Net Assets
Down$102,764,967
Down $14,138,905 (-12%) from 2015
Liabilities
Up$837,362
Up $71,652 (+9.4%) from 2015
Revenue
Down$4,559,867
Down $936,910 (-17%) from 2015
Expenses
Up$6,650,420
Up $1,831,537 (+38%) from 2015
Net Income
Down-$2,090,553
Down $2,768,447 (-408%) from 2015
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
As a supporting organization to the Clayton Foundation for Research (Clayton), the organizations primary mission is to fund medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through Claytons other supporting entities.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.